.jpg "Luigi Naldini, MD, PhD photo")
Director
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget)
Milan, Lombardia, Italy
Luigi Naldini is the Director of San Raffaele Telethon Institute for Gene Therapy, Milan, Italy, and Full Professor with Tenure at the San Raffaele Vita-Salute University, Milan. For the past 25 years he has pioneered the development and the applications of lentiviral vectors for gene therapy, which have become one of the most widely used tools in biomedical research and, upon recently entering clinical testing, are providing a long-sought hope of cures for several currently untreatable human diseases. Has published over 290 scientific papers. SCOPUS Author h-index: 105.
Luigi is Member of the European Molecular Biology Organization (EMBO), has been President of the European Society of Gene and Cell Therapy (ESGCT), and has been appointed as expert on the “Human Gene Editing Study” of the US National Academies of Sciences and of Medicine, and on the Italian National Committee for Biosafety, Biotechnology and Life Sciences. He was awarded the Outstanding Achievement Award from the American Society of Gene and Cell Therapy (ASGCT) in 2014 and from ESGCT in 2015, an Honorary doctorate from the Vrije University, Brussel, in 2015, the Jimenez Diaz Prize in 2016, the Beutler Prize from the American Society of Hematology (ASH) in 2017 and the 2019 Jeantet-Collen Prize for Translational Medicine. He was nominated “Grande Ufficiale dell’Ordine Al Merito della Repubblica Italiana”, one of the highest ranking honor in Italy, from the President of the Republic of Italy on December 27th, 2019 and was elected “Socio" at the “Accademia Nazionale dei Lincei”, on July 26th, 2022.
Disclosure information not submitted.
Thursday, June 22, 2023
2:20 PM – 2:45 PM
